首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Endothelin ET_A receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice
【24h】

Endothelin ET_A receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice

机译:内皮素ET_A受体阻滞剂可恢复载脂蛋白E缺乏症小鼠的NO介导的内皮功能并抑制动脉粥样硬化

获取原文
获取原文并翻译 | 示例
           

摘要

This study investigated whether endothelin-1 (ET-1), a potent vasoconstrictor, which also stimulates cell proliferation, contributes to endothelial dysfunction and ath- erosclerosis. Apolipoprotein E (apoE)-deficient mice and C57BL/6 control mice were treated with a Western-type diet to accelerate atherosclerosis with or without ETA receptor antagonist LU135252 (50 mg/kg/d) for 30 wk. Systolic blood pressure, plasma lipid profile, and plasma nitrate levels were determined. In the aorta, NO-mediated endothelium- dependent relaxation, atheroma formation, ET receptor- binding capacity, and vascular ET-1 protein content were assessed. In apoE-deficient but not C57BL/6 mice, severe atherosclerosis developed within 30 wk.
机译:这项研究调查了内皮素-1(ET-1),一种有效的血管收缩剂,它还能刺激细胞增殖,是否导致内皮功能障碍和动脉粥样硬化。用西式饮食处理载脂蛋白E(apoE)缺陷的小鼠和C57BL / 6对照小鼠,以在有或没有ETA受体拮抗剂LU135252(50 mg / kg / d)的情况下加速动脉粥样硬化,持续30周。测定收缩压,血浆脂质分布和血浆硝酸盐水平。在主动脉中,评估了NO介导的内皮依赖性舒张,动脉粥样硬化形成,ET受体结合能力和血管ET-1蛋白含量。在apoE缺陷型但不是C57BL / 6小鼠中,严重的动脉粥样硬化在30周内发生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号